Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Clinical trial NCT04503694 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04503694
- Sponsor
- Jules Bordet Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2026-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.